Cruz Cos. CEO has the ‘soul of the giver’

John B. Cruz III is the 15th recipient of the BBJ’s Alnoba Lewis Family Foundation CEO Social Leadership Award, given to an executive who goes beyond in creating solutions to help solve Greater Boston’s biggest community challenges. Read More

Read More

Obsidian Therapeutics eyes IPO after $115M fundraise

After raising $115 million from a handful of high-profile investors, cell and gene therapy startup Obsidian Therapeutics has its sights set on an IPO by early 2023. The company expects to advance its first cancer drug into the clinic in the same timeframe. It also plans to move to Bedford. Read More

Read More

Boston Beer once again lowers expectations for sales of hard seltzer

The company said Wednesday evening that it’s withdrawing its full-year financial guidance for 2021 issued in July during its most recent quarterly earnings, and that it now “expects to incur hard seltzer-related inventory write-offs, shortfall fees payable to third party brewers, and other costs that will be expensed during the remainder of fiscal 2021.” Read…

Read More